Kistler Tiffany Companies, LLC Gilead Sciences, Inc. Transaction History

Kistler Tiffany Companies, LLC

$615 Million
Q2 2023

A detailed history of Kistler Tiffany Companies, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Kistler Tiffany Companies, LLC holds 2,283 shares of GILD stock, worth $210,972. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,283

Previous 2,278 0.22%

Holding current value

$210,972

Previous $189,000 7.41%

% of portfolio

0.03%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 01, 2023	BUY	$76.01 - $86.7 $380 - $433	5 Added 0.22%	2,283 $175,000
Q1 2023 May 03, 2023	SELL	$77.31 - $88.08 $3,401 - $3,875	-44 Reduced 1.89%	2,278 $189,000
Q4 2022 Jan 27, 2023	SELL	$62.32 - $89.47 $90,613 - $130,089	-1,454 Reduced 38.51%	2,322 $199,000
Q3 2022 Nov 09, 2022	BUY	$59.54 - $68.01 $476 - $544	8 Added 0.21%	3,776 $233,000
Q2 2022 Aug 08, 2022	SELL	$57.72 - $65.01 $155,728 - $175,396	-2,698 Reduced 41.73%	3,768 $233,000
Q1 2022 May 11, 2022	BUY	$57.92 - $72.58 $278,073 - $348,456	4,801 Added 288.35%	6,466 $384,000
Q4 2021 Jan 25, 2022	SELL	$64.88 - $73.64 $15,765 - $17,894	-243 Reduced 12.74%	1,665 $121,000
Q3 2021 Nov 10, 2021	SELL	$67.69 - $73.03 $9,950 - $10,735	-147 Reduced 7.15%	1,908 $133,000
Q2 2021 Aug 04, 2021	BUY	$63.47 - $69.35 $30,275 - $33,079	477 Added 30.23%	2,055 $141,000
Q1 2021 May 07, 2021	BUY	$60.0 - $68.46 $1,320 - $1,506	22 Added 1.41%	1,578 $102,000
Q2 2020 Jul 20, 2020	SELL	$72.34 - $84.0 $34,216 - $39,732	-473 Reduced 23.31%	1,556 $120,000
Q4 2019 Jan 14, 2020	SELL	$61.62 - $67.78 $150,167 - $165,179	-2,437 Reduced 54.57%	2,029 $132,000
Q3 2019 Oct 18, 2019	SELL	$62.51 - $69.0 $53,508 - $59,064	-856 Reduced 16.08%	4,466 $283,000
Q2 2019 Jul 22, 2019	BUY	$61.87 - $69.38 $37,183 - $41,697	601 Added 12.73%	5,322 $360,000
Q1 2019 Apr 16, 2019	SELL	$62.53 - $70.05 $140,067 - $156,912	-2,240 Reduced 32.18%	4,721 $307,000
Q4 2018 Jan 14, 2019	SELL	$60.54 - $79.0 $64,535 - $84,214	-1,066 Reduced 13.28%	6,961 $435,000
Q3 2018 Oct 19, 2018	BUY	$71.28 - $78.92 $3,706 - $4,103	52 Added 0.65%	8,027 $620,000
Q2 2018 Jul 17, 2018	SELL	$64.88 - $75.68 $69,291 - $80,826	-1,068 Reduced 11.81%	7,975 $565,000
Q1 2018 Apr 06, 2018	SELL	$72.84 - $88.8 $10,561 - $12,876	-145 Reduced 1.58%	9,043 $682,000
Q4 2017 Jan 11, 2018	BUY	$71.15 - $83.52 $50,231 - $58,965	706 Added 8.32%	9,188 $658,000
Q3 2017 Oct 19, 2017	BUY	$72.11 - $85.47 $611,637 - $724,956	8,482	8,482 $687,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kistler Tiffany Companies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kistler Tiffany Companies, LLC with notifications on news.

Account

Kistler Tiffany Companies, LLC Gilead Sciences, Inc. Transaction History